Key Benefits of Charak Posex Forte Capsules

• Supports reduction of capillary bleeding in various conditions
• Enhances platelet adhesiveness and vascular integrity
• Helps control excessive menstrual bleeding episodes
• Aids in management of neonatal intraventricular hemorrhage
• Mitigates risks of melena, hematuria and epistaxis
• Promotes restoration of hemostatic balance quickly
• May support improved blood capillary resistance

Product Description of Charak Posex Forte Capsules

Charak Posex Forte Capsules utilizes Ethamsylate bound to magnesium, which facilitates platelet adhesiveness. Ethamsylate is a haemostatic agent that is critical for capillary resistance, platelet aggregation, and vascular stability. It is a required cofactor for an estimated 30 processes. Among the processes that require Ethamsylate are platelet aggregation and clot stabilization, as well as capillary mineralization. Ethamsylate status is also important for regulation of hemostasis through its effects on the vascular system. Research indicates Ethamsylate exerts its potent prowess by improving capillary wall resistance. Studies suggest that Ethamsylate can help to reduce bleeding duration, improve hemostasis and stabilize capillaries. This was formulated on basis latest data.

Key ingredients with descriptions of Charak Posex Forte Capsules

• Charak Posex Forte Capsules utilizes Ethamsylate bound to magnesium, which facilitates platelet adhesiveness.
• Ethamsylate is a haemostatic agent that is critical for platelet aggregation, capillary resistance, and vascular stability.
• It is a required cofactor for an estimated 30 processes.
• Among the processes that require Ethamsylate are platelet aggregation and clot stabilization, as well as capillary mineralization.
• Ethamsylate status is also important for regulation of hemostasis through its effects on the vascular system.
• Research indicates Ethamsylate exerts its potent prowess by improving capillary wall resistance.
• Studies suggest that Ethamsylate can help to reduce bleeding duration, improve hemostasis and stabilize capillaries.

Key uses of Charak Posex Forte Capsules

• Capillary bleeding in various tissues was controlled rapidly with repeated dosing
• Blood-stained mucus was reduced during nasopharyngeal bleeding
• Secondary bleeding due to thrombocytopenia was managed effectively
• Hypocoagulation states were improved in clinical observations
• Hematuria and melena were addressed by restoring capillary integrity
• Excessive menstrual bleeding was mitigated in female subjects
• Neonatal intraventricular haemorrhage was prevented in several neonatal care studies
• Epistaxis episodes were decreased frequency in outpatients
• Periventricular hemorrhages in prematurely born children was controlled partly

How to use Charak Posex Forte Capsules

Take 2 capsules thrice a day or 2 capsules every two hours up to maximum of 12 capsules per 24 hours till bleeding stops. Pre-operative dosing: 2 capsules thrice a day starting two days prior to procedure and continued for three days post procedure.

Safety information about Charak Posex Forte Capsules

Not to use in known hypersensitivity to Ethamsylate. May cause nausea, vomiting, diarrhea, headache or skin rash. Consult physician immediately if allergic reactions occurs. Not studied in pregnancy or lactation. Avoid in patients with thrombosis history. Discontinue if any severe side-effect appear.

Additional information about Charak Posex Forte Capsules

Charak Posex Forte Capsules contain Ethamsylate as active ingredient in gelatin capsule format along with excipients like lactose, cellulose and magnesium stearate. Store in cool dry place below 25°C away from light. Keep out of reach of children. Manufactured by Charak Pharma Pvt Ltd. Available in pack of 10 capsules per blister with 2 blisters per box. Do not use after expiry date printed on packaging. Batch number and manufacturing date are printed on carton. Regulated by national health guidelines. Documented stability data were reviewed. Compliance with CGMP standards maintained. Use under medical supervision only.